7.2- Cholesterol drugs Flashcards
Describe the infiltration and entrapment of LDL in the arterial wall
- LDL enters endothelium–> gets OXIDISED,enabling it to:
- inhibits macrophage motility
- Induces T-cell activation and VSMC division/differentiation
- Toxic to endothelial cells
- Enhances platelet aggregation
State the 4 main classes of lipid lowering drugs
- Statins e.g. Simvastatin
- Cholesterol lipase inhibitors e.g. Ezetimibe
- Nicotinic acid/niacin
- Fibrates e.g. Fenofibrate
What are the indications for the use of statins?
- CV risk prevention (CVD+DM)
- Familial hypercholesterolaemia
Describe the mechanism of action of statins
- Inhibits HMG-CoA reducatase in the pathway to cholesterol synthesis from Acetyl-Co-A
- Thereore inhibits choleserol synthesis in hepatocytes
- Increases clearance of LDL and IDL ( by increased synthesis of LDL receptor)
- Decreases production of VLDL and LDL
Give 3 adverse drug reactions of statins
- Inreased transaminsase levels ( sign of liver damage)
- Myopathy
- Miscellaneous; GI complaints, anthralgias, headaches and memory loss
What is seen in Myopathy resulting as a statin ADR?
- Diffuse muscle pain
- CK> 10 x upper normal limit
With which statin drug combos is a myopathy seen?
- Seen when HIGHER doses of statins are used in combination with
- Cyclosporine
Erythromycin and niacin
What are some secondary benefits of statin treatment? ( APIR)
- Anti-inflammatory
- Plaque reduction
- Improved endothelial cell function
- Reduced thrombotic risk
What statin therapy is recommended as part of primary prevention of CVD in adults w a high QRISK2?
Atorvastatin 20mg
If high 10-year risk of developing CVD
How are statins used as part of secondary prevention?
Atorvastatin 80 mg
How is the level of CVD risk calculated?
using the QRISK2 risk calculator
What is the statin of choice?
Atorvastatin
What are are Fibric Acid Derivatives?
- Ampipathic carboxylic acids
- PPARalpha receptors agonist; increases production of lipoprotein lipase
Describe the mechanism of action of fibric acid derivatives
- PPARalpha receptor agonist; increases production of lipoprotein lipase
- Increases FA uptake and oxidation
- Reduces triglyceride levels
- Increases LDL particle size and HDL-C levels
Direct vascular effects
Name 3 indications for the use of FDA’s
Adjunctive therapy to diet
Hypertriglyceridaemia
Combined hyperliidemia with low HDL who not respond to NA